Testing for aspirin hypersensitivity

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 7, 2002, Pages 562-565

  Bochenek, G ^a   Nizankowska, E ^a   Szczeklik, A ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANAMNESIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG RESPONSE; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION TEST; LABORATORY TEST; PRIORITY JOURNAL; PROVOCATION TEST; RHINOMANOMETRY; RISK FACTOR; SYMPTOM;

ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; BRONCHIAL PROVOCATION TESTS; DRUG HYPERSENSITIVITY; HUMANS; NASAL PROVOCATION TESTS;

EID: 0036089725     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.13447.x     Document Type: Editorial

References (33)

1. Adverse drug-reaction monitoring
2. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclo-oxygenase enzymes
3. Aspirin-induced rhinitis and asthma
4. Natural history of aspirin-induced asthma
5. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force
6. Long-term prognosis for near fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for near attack of asthma
7. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs
8. Aspirin intolerance. II. A prospective study in an atopic and normal population
9. Diagnosis, prevention and treatment of adverse reactions to aspirin and nonsteroidal antiinflammatory drugs
10. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study
11. Drug-induced asthma. NSAIDs, beta-blockers, and ACE inhibitors
12. Leukotrienes in aspirin-sensitive asthma
13. Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis
14. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics
15. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma
16. Pharmacological agents in bronchial provocation tests
17. Aspirin induced tolerance in aspirin-asthma detected by a new challenge test
18. Inhalative provocation mit lysin-azetylsalizylsaure bei analgetica-asthma syndrome
19. A new method of diagnosis of aspirin-induced asthma by inhalation test with water solution aspirin
20. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: Its repeatability, absence of a late-phase reaction, and the role of histamine
21. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma. Report of the Interasthma Working Group on Standardization of Inhalation Provocation Tests in Aspirin-Induced Asthma
22. Aspirin-sensitive rhinosinusitis/asthma: Spectrum of adverse reactions to aspirin
23. Study of mediators of anaphylaxis in nasal provocation in intolerant rhinitic patients
24. Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients
25. Inhalation and nasal challenge in the diagnosis of aspirin-induced asthma
26. Lysine-aspirin nasal provocation and anterior rhinomanometry for the diagnosis of aspirin-sensitive asthma
27. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma
28. Nasal provocation tests
29. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients
30. Safety of specific COX-2 inhibitor in aspirin-induced asthma
31. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma
32. Celecoxib in patients with asthma and aspirin-intolerance
33. Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma